Lactate dehydrogenase is a prognostic indicator for prostate cancer patients with bone metastasis

Acta Urologica Japonica

Volumn 53, Issue 5, 2007, Pages 287-292

  Naruse, Katsuya ^a   Yamada, Yoshiaki ^a   Aoki, Shigeyuki ^a   Taki, Tomohiro ^a   Nakamura, Kogenta ^a   Tobiume, Motoi ^a   Zennami, Kenji ^a   Katsuda, Remi ^a   Sai, Shotoku ^a   Nishmo, Yoshitaka ^a   Inoue, Yasusuke ^a   Noguchi, Hiroshi ^a   Honda, Nobuaki ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metastasis; Clinical study; Lactate dehydrogenase; Prognostic indicator; Prostate cancer

Indexed keywords

ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; BONE TUMOR; ENZYMOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE NEOPLASMS; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 34250891436     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ito K, Kubota Y, Yamamoto T, et al. : The change of mass screening system for prostate cancer in Gunma Prefecture, present state, and problems for 18 years. Jpn J Urol Surg 13 : 997-1001, 2000
2. Gleason DF : Histologic grading of prostate cancer : a perspective. Hum Pathol 23 : 273-279, 1992
3. th ed), Wiley-Liss Inc, 1977
4. Soloway MS, Hardemann SW, Hickey D, et al. : Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61: 195-202, 1988
5. Kumamoto Y, Tsukamoto T, Umehara T, et al. : Clinical studies on endocrine therapy for prostatic carcinoma (2) : prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses on causes of death and side effect of endcrine therapy. Hinyoukikakiyo 36: 285-293, 1990
6. Debes JD and Tindall DJ : Mechanisms of androgen-refractory prostate cancer. N Eng J Med 351: 1488-1490, 2004
7. Ernst DS, Hanson J, Vernner PM, et al. : Analysis of prognostic factors in men with metastatic prostate cancer. J Urol 146 : 372-376, 1991
8. Murphy GP and Whitmore WF Jr : A report of the workshops on the current status of the histologic grading of prostate cancer. Cancer 44: 1490-1494, 1979
9. Bostwick DG : Grading of prostate cancer. Am J Clin Pathol 102: S38-S56, 1994
10. Di Lorcto C, Fitzpatrick B, Underhill S, et al. : Correlation between visual clues, objective architectural features, and interobserver agreement in prostate cancer. Am J Clin Pathol 96 : 70 - 75, 1991